<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37434526</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-2954</ISSN><JournalIssue CitedMedium="Internet"><Volume>290</Volume><Issue>2002</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Proceedings. Biological sciences</Title><ISOAbbreviation>Proc Biol Sci</ISOAbbreviation></Journal><ArticleTitle>Epidemiological impacts of post-infection mortality.</ArticleTitle><Pagination><StartPage>20230343</StartPage><MedlinePgn>20230343</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20230343</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rspb.2023.0343</ELocationID><Abstract><AbstractText>Infectious diseases may cause some long-term damage to their host, leading to elevated mortality even after recovery. Mortality due to complications from so-called 'long COVID' is a stark illustration of this potential, but the impacts of such post-infection mortality (PIM) on epidemic dynamics are not known. Using an epidemiological model that incorporates PIM, we examine the importance of this effect. We find that in contrast to mortality during infection, PIM can induce epidemic cycling. The effect is due to interference between elevated mortality and reinfection through the previously infected susceptible pool. In particular, robust immunity (via decreased susceptibility to reinfection) reduces the likelihood of cycling; on the other hand, disease-induced mortality can interact with weak PIM to generate periodicity. In the absence of PIM, we prove that the unique endemic equilibrium is stable and therefore our key result is that PIM is an overlooked phenomenon that is likely to be destabilizing. Overall, given potentially widespread effects, our findings highlight the importance of characterizing heterogeneity in susceptibility (via both PIM and robustness of host immunity) for accurate epidemiological predictions. In particular, for diseases without robust immunity, such as SARS-CoV-2, PIM may underlie complex epidemiological dynamics especially in the context of seasonal forcing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saad-Roy</LastName><ForeName>Chadi M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-2217-3071</Identifier><AffiliationInfo><Affiliation>Miller Institute for Basic Research in Science, University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integrative Biology, University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Simon A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-8216-5639</Identifier><AffiliationInfo><Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grenfell</LastName><ForeName>Bryan T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public and International Affairs, Princeton University, Princeton, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boots</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3763-6136</Identifier><AffiliationInfo><Affiliation>Department of Integrative Biology, University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biosciences, University of Exeter, Penryn, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.c.6708367</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Proc Biol Sci</MedlineTA><NlmUniqueID>101245157</NlmUniqueID><ISSNLinking>0962-8452</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="N">Epidemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epidemiological model</Keyword><Keyword MajorTopicYN="N">periodicity</Keyword><Keyword MajorTopicYN="N">post-infection mortality</Keyword></KeywordList><CoiStatement>We declare we have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>3</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37434526</ArticleId><ArticleId IdType="pmc">PMC10336371</ArticleId><ArticleId IdType="doi">10.1098/rspb.2023.0343</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Uusk&#xfc;la A, et al. 2022. Long-term mortality following SARS-CoV-2 infection: a national cohort study from estonia. Lancet Reg. Health&#x2014;Eur. 18, 100394. (10.1016/j.lanepe.2022.100394)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100394</ArticleId><ArticleId IdType="pmc">PMC9051903</ArticleId><ArticleId IdType="pubmed">35505834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K, et al. 2022. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: a cohort study using linked primary care, secondary care, and death registration data in the opensafely platform. PLoS Med. 19, e1003871. (10.1371/journal.pmed.1003871)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003871</ArticleId><ArticleId IdType="pmc">PMC8789178</ArticleId><ArticleId IdType="pubmed">35077449</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. 2022. Long-term neurologic outcomes of COVID-19. Nat. Med. 28, 2406-2415. (10.1038/s41591-022-02001-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. 2022. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461-1467. (10.1038/s41591-022-01840-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. 2021. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259-264. (10.1038/s41586-021-03553-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson T, Lindstrom M. 2003. Airborne infectious diseases during infancy and mortality in later life in southern Sweden, 1766&#x2013;1894. Int. J. Epidemiol. 32, 286-294. (10.1093/ije/dyg061)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg061</ArticleId><ArticleId IdType="pubmed">12714551</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch CE, Crimmins EM. 2004. Inflammatory exposure and historical changes in human life-spans. Science 305, 1736-1739. (10.1126/science.1092556)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1092556</ArticleId><ArticleId IdType="pubmed">15375259</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimmins EM, Finch CE. 2006. Infection, inflammation, height, and longevity. Proc. Natl Acad. Sci. USA 103, 498-503. (10.1073/pnas.0501470103)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501470103</ArticleId><ArticleId IdType="pmc">PMC1326149</ArticleId><ArticleId IdType="pubmed">16387863</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. 2022. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583-590. (10.1038/s41591-022-01689-3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24, S1-S10. (10.1016/j.vaccine.2006.05.115)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2006.05.115</ArticleId><ArticleId IdType="pubmed">16949995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, et al. 2022. Longitudinal analysis reveals high prevalence of Epstein&#x2013;Barr virus associated with multiple sclerosis. Science 375, 296-301. (10.1126/science.abj8222)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8222</ArticleId><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell BT. 2015. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348, 694-699. (10.1126/science.aaa3662)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3662</ArticleId><ArticleId IdType="pmc">PMC4823017</ArticleId><ArticleId IdType="pubmed">25954009</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, et al. 2019. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 366, 599-606. (10.1126/science.aay6485)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay6485</ArticleId><ArticleId IdType="pmc">PMC8590458</ArticleId><ArticleId IdType="pubmed">31672891</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine KS, et al. 2023. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086-1093.e2. (10.1016/j.neuron.2022.12.029)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.12.029</ArticleId><ArticleId IdType="pmc">PMC10079561</ArticleId><ArticleId IdType="pubmed">36669485</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. 2008. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180, 2443-2449. (10.4049/jimmunol.180.4.2443)</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.4.2443</ArticleId><ArticleId IdType="pubmed">18250453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodzic Z, Schill EM, Bolock AM, Good M. 2017. IL-33 and the intestine: the good, the bad, and the inflammatory. Cytokine 100, 1-10. (10.1016/j.cyto.2017.06.017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2017.06.017</ArticleId><ArticleId IdType="pmc">PMC5650929</ArticleId><ArticleId IdType="pubmed">28687373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuenzig ME, Manuel DG, Donelle J, Benchimol EI. 2020. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease. CMAJ 192, E1394-E1402. (10.1503/cmaj.190976)</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.190976</ArticleId><ArticleId IdType="pmc">PMC7669301</ArticleId><ArticleId IdType="pubmed">33168761</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham AL, Schrom EC, Metcalf CJE. 2022. The evolution of powerful yet perilous immune systems. Trends Immunol. 43, 117-131. (10.1016/j.it.2021.12.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8686020</ArticleId><ArticleId IdType="pubmed">34949534</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson RM, May RM. 1979. Population biology of infectious diseases: part I. Nature 280, 361-367. (10.1038/280361a0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/280361a0</ArticleId><ArticleId IdType="pubmed">460412</ArticleId></ArticleIdList></Reference><Reference><Citation>May RM, Anderson RM. 1979. Population biology of infectious diseases: part II. Nature 280, 455-461. (10.1038/280455a0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/280455a0</ArticleId><ArticleId IdType="pubmed">460424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallos LK, Fefferman NH. 2015. The effect of disease-induced mortality on structural network properties. PLoS ONE 10, e0136704. (10.1371/journal.pone.0136704)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136704</ArticleId><ArticleId IdType="pmc">PMC4552173</ArticleId><ArticleId IdType="pubmed">26313926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rnstad ON, Shea K, Krzywinski M, Altman N. 2020. The SEIRS model for infectious disease dynamics. Nat. Methods 17, 557-558. (10.1038/s41592-020-0856-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-020-0856-2</ArticleId><ArticleId IdType="pubmed">32499633</ArticleId></ArticleIdList></Reference><Reference><Citation>Busenberg S, van den Driessche P. 1990. Analysis of a disease transmission model in a population with varying size. J. Math. Biol. 28, 257-270. (10.1007/BF00178776)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00178776</ArticleId><ArticleId IdType="pubmed">2332704</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SE, Pitzer VE, Viboud C, Metcalf CJE, Bj&#xf8;rnstad ON, Grenfell BT. 2015. Demographic buffering: titrating the effects of birth rate and imperfect immunity on epidemic dynamics. J. R. Soc. Interface 12, 20141245. (10.1098/rsif.2014.1245)</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2014.1245</ArticleId><ArticleId IdType="pmc">PMC4345488</ArticleId><ArticleId IdType="pubmed">25589567</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad-Roy C.M., et al. 2020. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science 370, 811-818. (10.1126/science.abd7343)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7343</ArticleId><ArticleId IdType="pmc">PMC7857410</ArticleId><ArticleId IdType="pubmed">32958581</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad-Roy CM, et al. 2021. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science 372, 363-370. (10.1126/science.abg8663)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg8663</ArticleId><ArticleId IdType="pmc">PMC8128287</ArticleId><ArticleId IdType="pubmed">33688062</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner CE, et al. 2021. Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science 373, eabj7364. (10.1126/science.abj7364)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj7364</ArticleId><ArticleId IdType="pmc">PMC9835930</ArticleId><ArticleId IdType="pubmed">34404735</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekmann O, Heesterbeek JAP, Metz JAJ. 1990. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28, 365-382. (10.1007/BF00178324)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00178324</ArticleId><ArticleId IdType="pubmed">2117040</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Driessche P, Watmough J. 2002. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180, 29-48. (10.1016/S0025-5564(02)00108-6)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-5564(02)00108-6</ArticleId><ArticleId IdType="pubmed">12387915</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker AD, Grenfell B. 2017. tsiR: an R package for time-series susceptible&#x2013;infected&#x2013;recovered models of epidemics. PLoS ONE 12, e0185528. (10.1371/journal.pone.0185528)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185528</ArticleId><ArticleId IdType="pmc">PMC5619791</ArticleId><ArticleId IdType="pubmed">28957408</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitzer VE, et al. 2009. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 325, 290-294. (10.1126/science.1172330)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1172330</ArticleId><ArticleId IdType="pmc">PMC3010406</ArticleId><ArticleId IdType="pubmed">19608910</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitzer VE, Viboud C, Alonso WJ, Wilcox T, Metcalf CJ, Steiner CA, Haynes AK, Grenfell BT, Kaderali L. 2015. Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States. PLoS Pathog. 11, e1004591. (10.1371/journal.ppat.1004591)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004591</ArticleId><ArticleId IdType="pmc">PMC4287610</ArticleId><ArticleId IdType="pubmed">25569275</ArticleId></ArticleIdList></Reference><Reference><Citation>Hethcote HW, Levin SA. 1989. Periodicity in epidemiological models. In Applied mathematical ecology (eds SA Levin, TG Hallam, LJ Gross), pp. 193&#x2013;211. Berlin, Heidelberg: Springer.</Citation></Reference><Reference><Citation>Liu WM, Levin SA, Iwasa Y. 1986. Influence of nonlinear incidence rates upon the behavior of SIRS epidemiological model. J. Math. Biol. 23, 187-204. (10.1007/BF00276956)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00276956</ArticleId><ArticleId IdType="pubmed">3958634</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WM, Hethcote HW, Levin SA. 1987. Dynamical behavior of epidemiological models with nonlinear incidence rates. J. Math. Biol. 25, 359-380. (10.1007/BF00277162)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00277162</ArticleId><ArticleId IdType="pubmed">3668394</ArticleId></ArticleIdList></Reference><Reference><Citation>Hethcote HW, Stech HW, van den Driessche P. 1981. Nonlinear oscillations in epidemic models. SIAM J. Appl. Math. 40, 1-9. (10.1137/0140001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1137/0140001</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;st G, Tekeli T. 2020. Stability and oscillations of multistage SIS models depend on the number of stages. Appl. Math. Comput. 380, 125259. (10.1016/j.amc.2020.125259)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amc.2020.125259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidbury HJ, Best A, Boots M. 2012. The epidemiological consequences of immune priming. Proc. R. Soc. B 279, 4505-4512. (10.1098/rspb.2012.1841)</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2012.1841</ArticleId><ArticleId IdType="pmc">PMC3479815</ArticleId><ArticleId IdType="pubmed">22977154</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad-Roy CM, Metcalf CJE, Grenfell BT. 2022. Immuno-epidemiology and the predictability of viral evolution. Science 376, 1161-1162. (10.1126/science.abn9410)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn9410</ArticleId><ArticleId IdType="pubmed">35679395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson N, Anderson R, Gupta S. 1999. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc. Natl Acad. Sci. USA 96, 790-794. (10.1073/pnas.96.2.790)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.2.790</ArticleId><ArticleId IdType="pmc">PMC15215</ArticleId><ArticleId IdType="pubmed">9892712</ArticleId></ArticleIdList></Reference><Reference><Citation>Arinaminpathy N, Riley S, Barclay WS, Saad-Roy C, Grenfell B. 2020. Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza. J. R. Soc. Interface 17, 20190879. (10.1098/rsif.2019.0879)</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2019.0879</ArticleId><ArticleId IdType="pmc">PMC7115234</ArticleId><ArticleId IdType="pubmed">32126190</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandon S, Mackinnon MJ, Nee S, Read AF. 2001. Imperfect vaccines and the evolution of pathogen virulence. Nature 414, 751-756. (10.1038/414751a)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/414751a</ArticleId><ArticleId IdType="pubmed">11742400</ArticleId></ArticleIdList></Reference><Reference><Citation>Read AF, et al. 2015. Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biol. 13, e1002198. (10.1371/journal.pbio.1002198)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002198</ArticleId><ArticleId IdType="pmc">PMC4516275</ArticleId><ArticleId IdType="pubmed">26214839</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. 2022. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case&#x2013;control study. Lancet Infect. Dis. 22, 43-55. (10.1016/S1473-3099(21)00460-6)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, Rescigno M. 2022. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA 328, 676-678. (10.1001/jama.2022.11691)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, et al. 2022. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020&#x2013;21, Israel. npj Vaccines 7, 101. (10.1038/s41541-022-00526-5)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. 2022. Trajectory of long COVID symptoms after COVID-19 vaccination: community based cohort study. BMJ 377, e069676. (10.1136/bmj-2021-069676)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>King A, Shrestha S, Harvill E, Bj&#xf8;rnstad O. 2009. Evolution of acute infections and the invasion&#x2013;persistence trade-off. Am. Nat. 173, 446-455. (10.1086/597217)</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/597217</ArticleId><ArticleId IdType="pmc">PMC4101379</ArticleId><ArticleId IdType="pubmed">19231966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastings A. 2018. Transient phenomena in ecology. Science 361, eaat6412. (10.1126/science.aat6412)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6412</ArticleId><ArticleId IdType="pubmed">30190378</ArticleId></ArticleIdList></Reference><Reference><Citation>Heggerud C, Abbott K, Hastings A. 2023. Transient dynamics. In Oxford bibliographies in ecology (ed. D Gibson). New York, NY: Oxford University Press.</Citation></Reference><Reference><Citation>Saad-Roy CM, Levin SA, Grenfell BT, Boots M. 2023. Epidemiological impacts of post-infection mortality. Figshare. (10.6084/m9.figshare.c.6708367)</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.c.6708367</ArticleId><ArticleId IdType="pmc">PMC10336371</ArticleId><ArticleId IdType="pubmed">37434526</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>